Global Neuroendocrine Tumor Drug Market Research Report 2017

December 2017 | 110 pages | ID: GBE2855F803EN
QYResearch

Abstracts

In this report, the global Neuroendocrine Tumor Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Neuroendocrine Tumor Drug in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Neuroendocrine Tumor Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Eisai
• Exelixis, Inc.
• Foresee Pharmaceuticals, LLC
• Hutchison MediPharma Limited
• Intezyne, Inc
• INVENT Pharmaceuticals, Inc.
• Ipsen S.A.
• Jiangsu Hengrui Medicine Co., Ltd.
• Karyopharm Therapeutics, Inc.
• Lexicon Pharmaceuticals, Inc.
• Midatech Pharma Plc.
• Millennium Pharmaceuticals, Inc.
• MolMed S.p.A.
• Northwest Biotherapeutics, Inc.
• Novartis AG
• OctreoPharm Sciences GmbH
• OXiGENE, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• mTOR protein inhibitors
• Tyrosine kinase 3 inhibitors
• Somatostatin receptor antagonists
• Growth hormone releasing factor antagonists
• Somatostatin receptor agonists
• Others

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Neuroendocrine Tumor Drug Market Research Report 2017

1 NEUROENDOCRINE TUMOR DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Neuroendocrine Tumor Drug
1.2 Neuroendocrine Tumor Drug Segment by Type (Product Category)
  1.2.1 Global Neuroendocrine Tumor Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Neuroendocrine Tumor Drug Production Market Share by Type (Product Category) in 2016
  1.2.3 mTOR protein inhibitors
  1.2.4 Tyrosine kinase 3 inhibitors
  1.2.5 Somatostatin receptor antagonists
  1.2.6 Growth hormone releasing factor antagonists
  1.2.7 Somatostatin receptor agonists
  1.2.8 Others
1.3 Global Neuroendocrine Tumor Drug Segment by Application
  1.3.1 Neuroendocrine Tumor Drug Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 Global Neuroendocrine Tumor Drug Market by Region (2012-2022)
  1.4.1 Global Neuroendocrine Tumor Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Neuroendocrine Tumor Drug (2012-2022)
  1.5.1 Global Neuroendocrine Tumor Drug Revenue Status and Outlook (2012-2022)
  1.5.2 Global Neuroendocrine Tumor Drug Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL NEUROENDOCRINE TUMOR DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Neuroendocrine Tumor Drug Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Neuroendocrine Tumor Drug Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Neuroendocrine Tumor Drug Production and Share by Manufacturers (2012-2017)
2.2 Global Neuroendocrine Tumor Drug Revenue and Share by Manufacturers (2012-2017)
2.3 Global Neuroendocrine Tumor Drug Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Neuroendocrine Tumor Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Neuroendocrine Tumor Drug Market Competitive Situation and Trends
  2.5.1 Neuroendocrine Tumor Drug Market Concentration Rate
  2.5.2 Neuroendocrine Tumor Drug Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NEUROENDOCRINE TUMOR DRUG CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Neuroendocrine Tumor Drug Capacity and Market Share by Region (2012-2017)
3.2 Global Neuroendocrine Tumor Drug Production and Market Share by Region (2012-2017)
3.3 Global Neuroendocrine Tumor Drug Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL NEUROENDOCRINE TUMOR DRUG SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Neuroendocrine Tumor Drug Consumption by Region (2012-2017)
4.2 North America Neuroendocrine Tumor Drug Production, Consumption, Export, Import (2012-2017)
4.3 Europe Neuroendocrine Tumor Drug Production, Consumption, Export, Import (2012-2017)
4.4 China Neuroendocrine Tumor Drug Production, Consumption, Export, Import (2012-2017)
4.5 Japan Neuroendocrine Tumor Drug Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Neuroendocrine Tumor Drug Production, Consumption, Export, Import (2012-2017)
4.7 India Neuroendocrine Tumor Drug Production, Consumption, Export, Import (2012-2017)

5 GLOBAL NEUROENDOCRINE TUMOR DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Neuroendocrine Tumor Drug Production and Market Share by Type (2012-2017)
5.2 Global Neuroendocrine Tumor Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Neuroendocrine Tumor Drug Price by Type (2012-2017)
5.4 Global Neuroendocrine Tumor Drug Production Growth by Type (2012-2017)

6 GLOBAL NEUROENDOCRINE TUMOR DRUG MARKET ANALYSIS BY APPLICATION

6.1 Global Neuroendocrine Tumor Drug Consumption and Market Share by Application (2012-2017)
6.2 Global Neuroendocrine Tumor Drug Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NEUROENDOCRINE TUMOR DRUG MANUFACTURERS PROFILES/ANALYSIS

7.1 Eisai
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Eisai Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Exelixis, Inc.
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Exelixis, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Foresee Pharmaceuticals, LLC
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Hutchison MediPharma Limited
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Hutchison MediPharma Limited Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Intezyne, Inc
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Intezyne, Inc Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 INVENT Pharmaceuticals, Inc.
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Ipsen S.A.
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Ipsen S.A. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Jiangsu Hengrui Medicine Co., Ltd.
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Karyopharm Therapeutics, Inc.
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Lexicon Pharmaceuticals, Inc.
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Neuroendocrine Tumor Drug Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Midatech Pharma Plc.
7.12 Millennium Pharmaceuticals, Inc.
7.13 MolMed S.p.A.
7.14 Northwest Biotherapeutics, Inc.
7.15 Novartis AG
7.16 OctreoPharm Sciences GmbH
7.17 OXiGENE, Inc.

8 NEUROENDOCRINE TUMOR DRUG MANUFACTURING COST ANALYSIS

8.1 Neuroendocrine Tumor Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Neuroendocrine Tumor Drug

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Neuroendocrine Tumor Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Neuroendocrine Tumor Drug Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NEUROENDOCRINE TUMOR DRUG MARKET FORECAST (2017-2022)

12.1 Global Neuroendocrine Tumor Drug Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Neuroendocrine Tumor Drug Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Neuroendocrine Tumor Drug Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Neuroendocrine Tumor Drug Price and Trend Forecast (2017-2022)
12.2 Global Neuroendocrine Tumor Drug Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Neuroendocrine Tumor Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Neuroendocrine Tumor Drug Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Neuroendocrine Tumor Drug Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Neuroendocrine Tumor Drug
Figure Global Neuroendocrine Tumor Drug Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Neuroendocrine Tumor Drug Production Market Share by Types (Product Category) in 2016
Figure Product Picture of mTOR protein inhibitors
Table Major Manufacturers of mTOR protein inhibitors
Figure Product Picture of Tyrosine kinase 3 inhibitors
Table Major Manufacturers of Tyrosine kinase 3 inhibitors
Figure Product Picture of Somatostatin receptor antagonists
Table Major Manufacturers of Somatostatin receptor antagonists
Figure Product Picture of Growth hormone releasing factor antagonists
Table Major Manufacturers of Growth hormone releasing factor antagonists
Figure Product Picture of Somatostatin receptor agonists
Table Major Manufacturers of Somatostatin receptor agonists
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Neuroendocrine Tumor Drug Consumption (K Pcs) by Applications (2012-2022)
Figure Global Neuroendocrine Tumor Drug Consumption Market Share by Applications in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Neuroendocrine Tumor Drug Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions (2012-2022)
Figure North America Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Neuroendocrine Tumor Drug Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Neuroendocrine Tumor Drug Capacity, Production (K Pcs) Status and Outlook (2012-2022)
Figure Global Neuroendocrine Tumor Drug Major Players Product Capacity (K Pcs) (2012-2017)
Table Global Neuroendocrine Tumor Drug Capacity (K Pcs) of Key Manufacturers (2012-2017)
Table Global Neuroendocrine Tumor Drug Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Neuroendocrine Tumor Drug Capacity (K Pcs) of Key Manufacturers in 2016
Figure Global Neuroendocrine Tumor Drug Capacity (K Pcs) of Key Manufacturers in 2017
Figure Global Neuroendocrine Tumor Drug Major Players Product Production (K Pcs) (2012-2017)
Table Global Neuroendocrine Tumor Drug Production (K Pcs) of Key Manufacturers (2012-2017)
Table Global Neuroendocrine Tumor Drug Production Share by Manufacturers (2012-2017)
Figure 2016 Neuroendocrine Tumor Drug Production Share by Manufacturers
Figure 2017 Neuroendocrine Tumor Drug Production Share by Manufacturers
Figure Global Neuroendocrine Tumor Drug Major Players Product Revenue (Million USD) (2012-2017)
Table Global Neuroendocrine Tumor Drug Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Neuroendocrine Tumor Drug Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Neuroendocrine Tumor Drug Revenue Share by Manufacturers
Table 2017 Global Neuroendocrine Tumor Drug Revenue Share by Manufacturers
Table Global Market Neuroendocrine Tumor Drug Average Price (USD/Pcs) of Key Manufacturers (2012-2017)
Figure Global Market Neuroendocrine Tumor Drug Average Price (USD/Pcs) of Key Manufacturers in 2016
Table Manufacturers Neuroendocrine Tumor Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Neuroendocrine Tumor Drug Product Category
Figure Neuroendocrine Tumor Drug Market Share of Top 3 Manufacturers
Figure Neuroendocrine Tumor Drug Market Share of Top 5 Manufacturers
Table Global Neuroendocrine Tumor Drug Capacity (K Pcs) by Region (2012-2017)
Figure Global Neuroendocrine Tumor Drug Capacity Market Share by Region (2012-2017)
Figure Global Neuroendocrine Tumor Drug Capacity Market Share by Region (2012-2017)
Figure 2016 Global Neuroendocrine Tumor Drug Capacity Market Share by Region
Table Global Neuroendocrine Tumor Drug Production by Region (2012-2017)
Figure Global Neuroendocrine Tumor Drug Production (K Pcs) by Region (2012-2017)
Figure Global Neuroendocrine Tumor Drug Production Market Share by Region (2012-2017)
Figure 2016 Global Neuroendocrine Tumor Drug Production Market Share by Region
Table Global Neuroendocrine Tumor Drug Revenue (Million USD) by Region (2012-2017)
Table Global Neuroendocrine Tumor Drug Revenue Market Share by Region (2012-2017)
Figure Global Neuroendocrine Tumor Drug Revenue Market Share by Region (2012-2017)
Table 2016 Global Neuroendocrine Tumor Drug Revenue Market Share by Region
Figure Global Neuroendocrine Tumor Drug Capacity, Production (K Pcs) and Growth Rate (2012-2017)
Table Global Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table North America Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Europe Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table China Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Japan Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Southeast Asia Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table India Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Table Global Neuroendocrine Tumor Drug Consumption (K Pcs) Market by Region (2012-2017)
Table Global Neuroendocrine Tumor Drug Consumption Market Share by Region (2012-2017)
Figure Global Neuroendocrine Tumor Drug Consumption Market Share by Region (2012-2017)
Figure 2016 Global Neuroendocrine Tumor Drug Consumption (K Pcs) Market Share by Region
Table North America Neuroendocrine Tumor Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Europe Neuroendocrine Tumor Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table China Neuroendocrine Tumor Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Japan Neuroendocrine Tumor Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Southeast Asia Neuroendocrine Tumor Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table India Neuroendocrine Tumor Drug Production, Consumption, Import & Export (K Pcs) (2012-2017)
Table Global Neuroendocrine Tumor Drug Production (K Pcs) by Type (2012-2017)
Table Global Neuroendocrine Tumor Drug Production Share by Type (2012-2017)
Figure Production Market Share of Neuroendocrine Tumor Drug by Type (2012-2017)
Figure 2016 Production Market Share of Neuroendocrine Tumor Drug by Type
Table Global Neuroendocrine Tumor Drug Revenue (Million USD) by Type (2012-2017)
Table Global Neuroendocrine Tumor Drug Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Neuroendocrine Tumor Drug by Type (2012-2017)
Figure 2016 Revenue Market Share of Neuroendocrine Tumor Drug by Type
Table Global Neuroendocrine Tumor Drug Price (USD/Pcs) by Type (2012-2017)
Figure Global Neuroendocrine Tumor Drug Production Growth by Type (2012-2017)
Table Global Neuroendocrine Tumor Drug Consumption (K Pcs) by Application (2012-2017)
Table Global Neuroendocrine Tumor Drug Consumption Market Share by Application (2012-2017)
Figure Global Neuroendocrine Tumor Drug Consumption Market Share by Applications (2012-2017)
Figure Global Neuroendocrine Tumor Drug Consumption Market Share by Application in 2016
Table Global Neuroendocrine Tumor Drug Consumption Growth Rate by Application (2012-2017)
Figure Global Neuroendocrine Tumor Drug Consumption Growth Rate by Application (2012-2017)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eisai Neuroendocrine Tumor Drug Production Growth Rate (2012-2017)
Figure Eisai Neuroendocrine Tumor Drug Production Market Share (2012-2017)
Figure Eisai Neuroendocrine Tumor Drug Revenue Market Share (2012-2017)
Table Exelixis, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Exelixis, Inc. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Exelixis, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2012-2017)
Figure Exelixis, Inc. Neuroendocrine Tumor Drug Production Market Share (2012-2017)
Figure Exelixis, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2012-2017)
Table Foresee Pharmaceuticals, LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production Growth Rate (2012-2017)
Figure Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Production Market Share (2012-2017)
Figure Foresee Pharmaceuticals, LLC Neuroendocrine Tumor Drug Revenue Market Share (2012-2017)
Table Hutchison MediPharma Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hutchison MediPharma Limited Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production Growth Rate (2012-2017)
Figure Hutchison MediPharma Limited Neuroendocrine Tumor Drug Production Market Share (2012-2017)
Figure Hutchison MediPharma Limited Neuroendocrine Tumor Drug Revenue Market Share (2012-2017)
Table Intezyne, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Intezyne, Inc Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Intezyne, Inc Neuroendocrine Tumor Drug Production Growth Rate (2012-2017)
Figure Intezyne, Inc Neuroendocrine Tumor Drug Production Market Share (2012-2017)
Figure Intezyne, Inc Neuroendocrine Tumor Drug Revenue Market Share (2012-2017)
Table INVENT Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2012-2017)
Figure INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Market Share (2012-2017)
Figure INVENT Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2012-2017)
Table Ipsen S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ipsen S.A. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ipsen S.A. Neuroendocrine Tumor Drug Production Growth Rate (2012-2017)
Figure Ipsen S.A. Neuroendocrine Tumor Drug Production Market Share (2012-2017)
Figure Ipsen S.A. Neuroendocrine Tumor Drug Revenue Market Share (2012-2017)
Table Jiangsu Hengrui Medicine Co., Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production Growth Rate (2012-2017)
Figure Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Production Market Share (2012-2017)
Figure Jiangsu Hengrui Medicine Co., Ltd. Neuroendocrine Tumor Drug Revenue Market Share (2012-2017)
Table Karyopharm Therapeutics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2012-2017)
Figure Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Production Market Share (2012-2017)
Figure Karyopharm Therapeutics, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2012-2017)
Table Lexicon Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Capacity, Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Growth Rate (2012-2017)
Figure Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Production Market Share (2012-2017)
Figure Lexicon Pharmaceuticals, Inc. Neuroendocrine Tumor Drug Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuroendocrine Tumor Drug
Figure Manufacturing Process Analysis of Neuroendocrine Tumor Drug
Figure Neuroendocrine Tumor Drug Industrial Chain Analysis
Table Raw Materials Sources of Neuroendocrine Tumor Drug Major Manufacturers in 2016
Table Major Buyers of Neuroendocrine Tumor Drug
Table Distributors/Traders List
Figure Global Neuroendocrine Tumor Drug Capacity, Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Neuroendocrine Tumor Drug Price (Million USD) and Trend Forecast (2017-2022)
Table Global Neuroendocrine Tumor Drug Production (K Pcs) Forecast by Region (2017-2022)
Figure Global Neuroendocrine Tumor Drug Production Market Share Forecast by Region (2017-2022)
Table Global Neuroendocrine Tumor Drug Consumption (K Pcs) Forecast by Region (2017-2022)
Figure Global Neuroendocrine Tumor Drug Consumption Market Share Forecast by Region (2017-2022)
Figure North America Neuroendocrine Tumor Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure North America Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Neuroendocrine Tumor Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Europe Neuroendocrine Tumor Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Neuroendocrine Tumor Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure China Neuroendocrine Tumor Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Neuroendocrine Tumor Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Japan Neuroendocrine Tumor Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Neuroendocrine Tumor Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure Southeast Asia Neuroendocrine Tumor Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Neuroendocrine Tumor Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Figure India Neuroendocrine Tumor Drug Production (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Neuroendocrine Tumor Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Neuroendocrine Tumor Drug Production, Consumption, Export and Import (K Pcs) Forecast (2017-2022)
Table Global Neuroendocrine Tumor Drug Production (K Pcs) Forecast by Type (2017-2022)
Figure Global Neuroendocrine Tumor Drug Production (K Pcs) Forecast by Type (2017-2022)
Table Global Neuroendocrine Tumor Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Neuroendocrine Tumor Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global Neuroendocrine Tumor Drug Price Forecast by Type (2017-2022)
Table Global Neuroendocrine Tumor Drug Consumption (K Pcs) Forecast by Application (2017-2022)
Figure Global Neuroendocrine Tumor Drug Consumption (K Pcs) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source